Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tetanus vaccine SSI
- Development stage
- Approved
- Lead developer
- Statens Serum Institut
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Tetanus Vaccine SSI is a monovalent tetanus toxoid vaccine originally produced by Statens Serum Institut (SSI), a Danish public health and biopharmaceutical company, and currently manufactured by AJ Vaccines. Its active ingredient is a formaldehyde-inactivated Clostridium tetani toxoid, which stimulates the immune system to produce protective antibodies against tetanus toxin. It is indicated for active immunization against tetanus (lockjaw). In clinical trials, such as a Phase 4 Swedish study sponsored by Örebro Läns Landsting, Tetanus Vaccine SSI has been evaluated as a separate-component reference vaccine to restore vaccine-acquired immunity lost following autologous or allogeneic hematopoietic stem cell transplantation.
- Brand names
- Tetanus vaccine SSITetanusvaccine SSI
- Other names
- tetanus toxoid vaccine SSItetanus vaccine (SSI)
02
Targets
TTC (Tetanus neurotoxin heavy chain fragment C)
Beyond the preview
Go deeper on tetanus vaccine SSI.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tetanus vaccine SSI.